Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,062
NCT03441984
To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers
Phase: Phase 1
Role: Collaborator
Start: Feb 26, 2018
Completion: Apr 28, 2018
NCT03354273
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
Phase: Phase 3
Start: Jun 5, 2018
Completion: May 5, 2022
NCT06263517
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
Phase: Phase 2/3
Start: Oct 12, 2023
Completion: Oct 31, 2025